Completed NA INTERVENTIONAL 1-arm NCT01307566

Evolution With CPAP Treatment of a Cohort of Type 2 Diabetic Patients With Apnea-hypopnea Syndrome (DM2-CPAP)

Evolution With CPAP Treatment of a Cohort of Type 2 Diabetic Patients With Moderate to Severe Apnea-hypopnea Syndrome and Poor Glycemic Control

Sponsor: EsteveTeijin Healthcare

Conditions Sleep Apnea Type 2 Diabetes

Interventions Continuous Positive Airway Pressure CPAP

Updated 5 times since 2017 Last updated: Jan 5, 2015 Started: Mar 31, 2011 Primary completion: Dec 31, 2014 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Sleep Apnea and Type 2 Diabetes, this trial is completed. The trial is conducted by EsteveTeijin Healthcare and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

EsteveTeijin Healthcare
Hospital de Granollers

Data source: Hospital de Granollers

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Granollers, Spain